Kezar Life Sciences, Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $51 M for Kezar Life Sciences, Inc., 1767 times as much (market caps of Mar 8, 2026 for Kezar Life Sciences, Inc. and Oct 30, 2026 for Moderna, Inc.). Kezar Life Sciences, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
- Both made a net loss: $54 M for Kezar Life Sciences, Inc. and $2.8 B for Moderna, Inc.
- Moderna, Inc. employs more people: 4,700 against 56 at Kezar Life Sciences, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Kezar Life Sciences, Inc. KZR | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2015 | 2010 |
| Size | ||
| Market cap | $51 M* | $90.1 B |
| Revenue | $0 M | $1.9 B |
| Net income | $-54 M▲ best | $-2.8 B |
| Employees | 56 | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Mar 2026 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Kezar Life Sciences, Inc. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $51 M for Kezar Life Sciences, Inc., 1767 times as much (market caps of Mar 8, 2026 for Kezar Life Sciences, Inc. and Oct 30, 2026 for Moderna, Inc.). Kezar Life Sciences, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Kezar Life Sciences, Inc. or Moderna, Inc.?
Both made a net loss: $54 M for Kezar Life Sciences, Inc. and $2.8 B for Moderna, Inc.
Which has more employees, Kezar Life Sciences, Inc. or Moderna, Inc.?
Moderna, Inc. employs more people: 4,700 against 56 at Kezar Life Sciences, Inc.